InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
KPTI
Result 348 decisions over 120 months
Reset filters
Direction ?
Both348 Bought4 Sold344
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: KPTI
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
KPTI Karyopharm Therapeutics Inc.
18 Feb 2021
Frenkel Ran
EVP, Chief Dev. Officer
Sold, plan not stated
2,887
$42.82K
5.9%
KPTI Karyopharm Therapeutics Inc.
18 Feb 2021
Shah Jatin
EVP, Chief Medical Officer
Sold, plan not stated
1,186
$17.59K
2.2%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
Shacham Sharon
President & CSO
Sold, plan not stated
6,642
$103.08K
0.9%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
6,642
$103.08K
0.9%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
Shacham Sharon
President & CSO indirect
Sold, plan not stated
6,601
$102.44K
1.2%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
6,601
$102.44K
1.2%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
Mason Michael
SVP, CFO & Treasurer
Sold, plan not stated
2,858
$44.35K
35.1%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
Lewis Tanya
EVP, Chief Reg. Affairs
Sold, plan not stated
2,046
$31.75K
33.1%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
Frenkel Ran
EVP, Chief Dev. Officer
Sold, plan not stated
2,046
$31.75K
4.9%
KPTI Karyopharm Therapeutics Inc.
11 Feb 2021
Shah Jatin
EVP, Chief Medical Officer
Sold, plan not stated
1,748
$27.13K
3.5%
KPTI Karyopharm Therapeutics Inc.
18 Dec 2020
Mirza Mansoor Raza
Director
Sold, plan not stated
5,000
$90.00K
100%
KPTI Karyopharm Therapeutics Inc.
7 Dec 2020
Mirza Mansoor Raza
Director
Sold, plan not stated 4×
20,000
$321.38K
100%
KPTI Karyopharm Therapeutics Inc.
1 Dec 2020
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated 2×
137,061
$2.40M
96.8%
KPTI Karyopharm Therapeutics Inc.
2 Nov 2020
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated
772
$11.52K
14.6%
KPTI Karyopharm Therapeutics Inc.
30 Oct 2020
Lewis Tanya
EVP,Chief Reg.&Quality Officer
Sold, plan not stated
226
$3.52K
29.5%
KPTI Karyopharm Therapeutics Inc.
13 Oct 2020
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated 2×
39,271
$661.97K
89.4%
KPTI Karyopharm Therapeutics Inc.
12 Oct 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
7,500
$111.68K
1.0%
KPTI Karyopharm Therapeutics Inc.
12 Oct 2020
Shacham Sharon
President & CSO
Sold, plan not stated
7,500
$111.68K
1.0%
KPTI Karyopharm Therapeutics Inc.
8 Sep 2020
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated
10,054
$150.61K
68.4%
KPTI Karyopharm Therapeutics Inc.
26 Aug 2020
DEMAREE JOHN
Chief Commercial Officer
Bought
7,500
$109.01K
opened
KPTI Karyopharm Therapeutics Inc.
17 Aug 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
1,477
$22.16K
0.2%
KPTI Karyopharm Therapeutics Inc.
17 Aug 2020
Shacham Sharon
President & CSO
Sold, plan not stated
1,477
$22.16K
0.2%
KPTI Karyopharm Therapeutics Inc.
15 Jul 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
7,500
$145.72K
1.0%
KPTI Karyopharm Therapeutics Inc.
15 Jul 2020
Shacham Sharon
President & CSO
Sold, plan not stated
7,500
$145.72K
1.0%
KPTI Karyopharm Therapeutics Inc.
15 Jul 2020
Shah Jatin
EVP, Chief Medical Officer
Sold, plan not stated
589
$11.46K
1.3%
KPTI Karyopharm Therapeutics Inc.
10 Jul 2020
Kauffman Michael
Chief Executive Officer
Sold, plan not stated 2×
7,500
$142.54K
1.3%
KPTI Karyopharm Therapeutics Inc.
10 Jul 2020
Shacham Sharon
President & CSO indirect
Sold, plan not stated 2×
7,500
$142.54K
1.3%
KPTI Karyopharm Therapeutics Inc.
9 Jul 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
7,500
$146.49K
1.0%
KPTI Karyopharm Therapeutics Inc.
9 Jul 2020
Shacham Sharon
President & CSO
Sold, plan not stated
7,500
$146.49K
1.0%
KPTI Karyopharm Therapeutics Inc.
22 Jun 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
7,500
$150.00K
1.0%
KPTI Karyopharm Therapeutics Inc.
22 Jun 2020
Shacham Sharon
President & CSO
Sold, plan not stated
7,500
$150.00K
1.0%
KPTI Karyopharm Therapeutics Inc.
15 Jun 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated 2×
7,500
$122.78K
1.0%
KPTI Karyopharm Therapeutics Inc.
15 Jun 2020
Shacham Sharon
President & CSO
Sold, plan not stated 2×
7,500
$122.78K
1.0%
KPTI Karyopharm Therapeutics Inc.
10 Jun 2020
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
7,500
$135.94K
1.3%
KPTI Karyopharm Therapeutics Inc.
10 Jun 2020
Shacham Sharon
President & CSO indirect
Sold, plan not stated
7,500
$135.94K
1.3%
KPTI Karyopharm Therapeutics Inc.
9 Jun 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
7,500
$138.75K
1.0%
KPTI Karyopharm Therapeutics Inc.
9 Jun 2020
Shacham Sharon
President & CSO
Sold, plan not stated
7,500
$138.75K
1.0%
KPTI Karyopharm Therapeutics Inc.
18 May 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
7,500
$150.00K
1.0%
KPTI Karyopharm Therapeutics Inc.
18 May 2020
Shacham Sharon
President & CSO
Sold, plan not stated
7,500
$150.00K
1.0%
KPTI Karyopharm Therapeutics Inc.
15 May 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
7,500
$139.84K
1.0%
KPTI Karyopharm Therapeutics Inc.
15 May 2020
Shacham Sharon
President & CSO
Sold, plan not stated
7,500
$139.84K
1.0%
KPTI Karyopharm Therapeutics Inc.
7 May 2020
Primiano Christopher Brett
EVP, CBO, GC & Secretary
Sold, plan not stated 2×
9,660
$190.63K
67.5%
KPTI Karyopharm Therapeutics Inc.
7 May 2020
Shacham Sharon
President & CSO indirect
Sold, plan not stated
7,500
$147.21K
1.3%
KPTI Karyopharm Therapeutics Inc.
7 May 2020
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
7,500
$147.21K
1.3%
KPTI Karyopharm Therapeutics Inc.
7 May 2020
Shacham Sharon
President & CSO
Sold, plan not stated
7,500
$147.20K
1.0%
KPTI Karyopharm Therapeutics Inc.
7 May 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
7,500
$147.20K
1.0%
KPTI Karyopharm Therapeutics Inc.
7 May 2020
Frenkel Ran
Chief Dev Operations Officer
Sold, plan not stated
1,974
$39.48K
5.3%
KPTI Karyopharm Therapeutics Inc.
9 Apr 2020
Kauffman Michael
Chief Executive Officer
Sold, plan not stated
10,000
$206.40K
1.8%
KPTI Karyopharm Therapeutics Inc.
9 Apr 2020
Shacham Sharon
President & CSO indirect
Sold, plan not stated
10,000
$206.40K
1.8%
KPTI Karyopharm Therapeutics Inc.
8 Apr 2020
Kauffman Michael
Chief Executive Officer indirect
Sold, plan not stated
10,000
$186.12K
1.3%
Showing 151–200 of 348. ← Newer Page 4 of 7 Older →